Akio Uemura serves as Senior Vice President and Managing Director, DIA Japan, where he is responsible for DIA business and program development. He works closely with the Advisory Council of Japan and its committees, as well as with industry, academia, and regulatory counterparts throughout Asia, to enhance and coordinate DIA’s collaborative networking, information exchange, and other efforts in Japan. He also supervises DIA Japan office staff, and serves on DIA’s Executive Leadership Team.
Prior to joining DIA, Dr. Uemura served as Executive Director, Head of Japan Development, Allergan Japan, where he previously served as Director and Head, Allergan Japan Regulatory Affairs. Before Allergan, Dr. Uemura was Director, Regulatory Policy, Liaison and Intelligence at Eli Lilly Japan, having served previously as Global Project Team Leader for early clinical phase projects at Eli Lilly & Co in Indianapolis, IN (US). He also held other managerial positions at Eli Lilly and Mochida Pharmaceuticals after earning his PhD in Bioengineering Sciences from Osaka University (Japan). Dr. Uemura has been a committed DIA volunteer for many years, serving on our Japan Regional Advisory Council as well as regularly participating as a speaker in numerous DIA meetings and conferences.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China